Bourret, Pascale; Keating, Peter; Cambrosio, Alberto - In: Social Science & Medicine 73 (2011) 6, pp. 816-824
In recent years, genomic technologies have entered oncology. In particular, so-called tumor signatures are now commercially available for diagnosing breast cancer. These new diagnostic tools have expanded the content and meaning of diagnosis, by adding a distinctive prognostic (will the disease...